NO20060676L - Parasittisidiske sammensetninger - Google Patents
Parasittisidiske sammensetningerInfo
- Publication number
- NO20060676L NO20060676L NO20060676A NO20060676A NO20060676L NO 20060676 L NO20060676 L NO 20060676L NO 20060676 A NO20060676 A NO 20060676A NO 20060676 A NO20060676 A NO 20060676A NO 20060676 L NO20060676 L NO 20060676L
- Authority
- NO
- Norway
- Prior art keywords
- closantel
- salisyl
- bioavailability
- acid compositions
- antiparasitic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 230000003071 parasitic effect Effects 0.000 title 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 abstract 3
- 229950004178 closantel Drugs 0.000 abstract 3
- 230000002141 anti-parasite Effects 0.000 abstract 2
- 239000003096 antiparasitic agent Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- -1 polyoxypropylene Polymers 0.000 abstract 2
- 239000005660 Abamectin Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 230000037058 blood plasma level Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 229960000502 poloxamer Drugs 0.000 abstract 1
- 229920001983 poloxamer Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920001451 polypropylene glycol Polymers 0.000 abstract 1
- 150000003873 salicylate salts Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
- A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Road Paving Structures (AREA)
- Toxicology (AREA)
Abstract
En antiparasittisidisk sammensetning presentert som et topisk "flytende" produkt for å behandle dyr infisert av parasitter som er kjent for å være følsomme for salisylanihder, spesielt closantel, alene eUer sammen med minst en annen antiparasittisk forbindelse av avermectin eller milbemycintype og gir fremmet biotilgjengehghet av salisylanilidet ved fremskaffelse av et avleveringssystem omfattende minst 20 % (v/v) av en eUer flere alkoholer og som eventuelt inkluderer en polymerenhet valgt fra gruppen bestående av polyvinylpyrrohdon (PVP), polyoksypropylen/polyoksyetylen blokk-kopolymerer (poloksamer) og polyetylenglykoler (PEG), derved bedres biotUgjengeligheten tU for eksempel closantel (som anslått når det gjelder closantels blodplasmanivåer).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0316377.1A GB0316377D0 (en) | 2003-07-12 | 2003-07-12 | Parasiticidal composition |
| PCT/GB2004/003006 WO2005007241A1 (en) | 2003-07-12 | 2004-07-12 | Parasiticidal composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20060676L true NO20060676L (no) | 2006-02-10 |
| NO336181B1 NO336181B1 (no) | 2015-06-08 |
Family
ID=27742085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060676A NO336181B1 (no) | 2003-07-12 | 2006-02-10 | Antiparasittiske flytende sammensetninger med salisylanilid og transdermalt avleveringssystem |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8993546B2 (no) |
| EP (2) | EP1646425B1 (no) |
| JP (1) | JP4677405B2 (no) |
| KR (1) | KR101095419B1 (no) |
| CN (1) | CN1822880B (no) |
| AP (1) | AP2956A (no) |
| AU (1) | AU2004257450B2 (no) |
| BR (1) | BRPI0412522A (no) |
| CA (1) | CA2532199C (no) |
| CR (1) | CR8174A (no) |
| DK (1) | DK1646425T3 (no) |
| EA (1) | EA009602B1 (no) |
| EC (1) | ECSP066360A (no) |
| ES (1) | ES2390224T3 (no) |
| GB (2) | GB0316377D0 (no) |
| GE (1) | GEP20094648B (no) |
| HR (1) | HRP20120721T1 (no) |
| IL (1) | IL173057A (no) |
| MX (1) | MXPA06000135A (no) |
| NO (1) | NO336181B1 (no) |
| NZ (1) | NZ544973A (no) |
| OA (1) | OA13188A (no) |
| PL (1) | PL1646425T3 (no) |
| PT (1) | PT1646425E (no) |
| SI (1) | SI1646425T1 (no) |
| TN (1) | TNSN06006A1 (no) |
| WO (1) | WO2005007241A1 (no) |
| ZA (1) | ZA200600374B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002952597A0 (en) * | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
| GB0501220D0 (en) * | 2005-01-21 | 2005-03-02 | Norbrook Lab Ltd | Anthelmintic composition |
| GB0711957D0 (en) * | 2007-06-21 | 2007-08-01 | Syntopix Ltd | Formulations |
| CN101693009B (zh) * | 2009-10-27 | 2010-12-01 | 纽素乐必佳（天津）药业集团有限公司 | 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法 |
| FR2991173B1 (fr) | 2012-06-04 | 2015-11-06 | Virbac | Composition veterinaire a administration cutanee a base d'oxyclozanide |
| CN103720652B (zh) * | 2014-01-07 | 2016-09-28 | 王玉万 | 用泊洛沙姆和油性介质制备含阿维菌素类药物注射剂 |
| WO2019054967A2 (en) * | 2017-03-15 | 2019-03-21 | Verano Ilac Sanayi Ve Ticaret Anonim Sirketi | VETERINARY COMPOSITION TO BE POURED COMPRISING EPRINOMECTIN |
| GB201715122D0 (en) * | 2017-09-19 | 2017-11-01 | Omnipharm Dev Ltd | Topical anti-infective formulation |
| BR112021006821A2 (pt) * | 2018-10-12 | 2021-07-13 | Hovione Scientia Limited | método de tratamento de inflamação e patologias oftálmicas, dispersão sólida, formulação farmacêutica, método de matar ácaros e kit |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2731386A (en) * | 1951-09-06 | 1956-01-17 | Wallace & Tiernan Company Inc | Antifungal composition |
| US3798258A (en) * | 1970-03-13 | 1974-03-19 | Merck & Co Inc | Salicylanilides |
| LU62350A1 (no) * | 1970-12-31 | 1972-08-23 | ||
| US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
| US4005218A (en) | 1975-03-18 | 1977-01-25 | Janssen Pharmaceutica N.V. | Antiparasitic salicylanilide derivatives |
| SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4201861A (en) | 1977-10-03 | 1980-05-06 | Merck & Co., Inc. | Acyl derivatives of C-076 compounds |
| US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
| US4206205A (en) | 1977-10-03 | 1980-06-03 | Merck & Co., Inc. | Monosaccharide and aglycone derivatives of C-076 |
| US4171314A (en) | 1977-12-19 | 1979-10-16 | Merck & Co., Inc. | 13-Halo and 13-deoxy C-076 compounds |
| US4173571A (en) | 1977-12-19 | 1979-11-06 | Merck & Co., Inc. | 13-Halo and 13-deoxy derivatives of C-076 compounds |
| NZ197796A (en) | 1980-08-04 | 1984-11-09 | Merck & Co Inc | Stabilised aqueous formulations containing ivermectin |
| NZ210505A (en) | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
| NZ335166A (en) | 1999-04-14 | 2001-11-30 | Ashmont Holdings Ltd | Anthelmintic composition containing triclabendazole in at least one solvent |
| RU2033150C1 (ru) | 1992-06-10 | 1995-04-20 | Виктор Антонович Дриняев | Препарат для лечения и профилактики псороптоза у животных "аверсект" |
| PL174488B1 (pl) * | 1993-05-10 | 1998-08-31 | Merck & Co Inc | Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt |
| WO1994027598A1 (en) * | 1993-05-26 | 1994-12-08 | Commonwealth Scientific And Industrial Research Organisation | Antiparasitic compositions |
| DE69432985D1 (de) | 1993-06-15 | 2003-09-04 | Australian Nat University Acto | Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien |
| NZ248486A (en) * | 1993-08-24 | 1996-07-26 | Ashmont Holdings Limited Subst | Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent |
| FR2739778B1 (fr) * | 1995-10-13 | 1997-12-12 | Virbac Lab | Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal |
| RU2112508C1 (ru) | 1995-12-26 | 1998-06-10 | Писков Вячеслав Борисович | Способ лечения и профилактики саркоптоидозов животных |
| RU2121831C1 (ru) | 1997-08-01 | 1998-11-20 | Анатолий Александрович Непоклонов | Препарат для профилактики и лечения гиподерматоза крупного рогатого скота |
| AUPP105497A0 (en) * | 1997-12-19 | 1998-01-15 | Schering-Plough Animal Health Limited | Aqueous insecticidal pour-on treatment |
| RU2129430C1 (ru) | 1998-03-17 | 1999-04-27 | Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" | Препарат для борьбы с экто- и эндопаразитами животных "сантомектин" |
| US6239119B1 (en) * | 1998-04-27 | 2001-05-29 | Medimmune Oncology, Inc. | Topical administration of amifostine and related compounds |
| GB9816132D0 (en) * | 1998-07-24 | 1998-09-23 | Norbrook Lab Ltd | Non-aqueous anthelmintic composition |
| GEP20012490B (en) | 1999-10-21 | 2001-07-25 | Robizon Bostashvili | Means Against Demodicosis of Agricultural and Domestic Animals |
| US6340672B1 (en) | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
| US6399651B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
| AUPQ875700A0 (en) * | 2000-07-13 | 2000-08-03 | Reflex Research Limited | Combination compositions |
| WO2002098404A1 (en) * | 2001-06-01 | 2002-12-12 | Tendskin Company | Topical compositions for veterinary uses |
| GB2386067A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species |
| AU2002952597A0 (en) * | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
| AU2003275779B2 (en) * | 2002-11-11 | 2009-02-05 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
| AU2003900505A0 (en) * | 2003-02-05 | 2003-02-20 | Jurox Pty Ltd | Anthelmintic composition |
-
2003
- 2003-07-12 GB GBGB0316377.1A patent/GB0316377D0/en not_active Ceased
-
2004
- 2004-07-12 PL PL04743347T patent/PL1646425T3/pl unknown
- 2004-07-12 EA EA200600237A patent/EA009602B1/ru not_active IP Right Cessation
- 2004-07-12 GB GB0415541A patent/GB2403905B/en not_active Expired - Lifetime
- 2004-07-12 PT PT04743347T patent/PT1646425E/pt unknown
- 2004-07-12 EP EP04743347A patent/EP1646425B1/en not_active Expired - Lifetime
- 2004-07-12 EP EP10012261A patent/EP2286876A1/en not_active Withdrawn
- 2004-07-12 CN CN200480020006XA patent/CN1822880B/zh not_active Expired - Fee Related
- 2004-07-12 ES ES04743347T patent/ES2390224T3/es not_active Expired - Lifetime
- 2004-07-12 JP JP2006519991A patent/JP4677405B2/ja not_active Expired - Lifetime
- 2004-07-12 NZ NZ544973A patent/NZ544973A/en not_active IP Right Cessation
- 2004-07-12 KR KR1020067000779A patent/KR101095419B1/ko not_active Expired - Fee Related
- 2004-07-12 SI SI200431947T patent/SI1646425T1/sl unknown
- 2004-07-12 OA OA1200600008A patent/OA13188A/en unknown
- 2004-07-12 AP AP2006003506A patent/AP2956A/xx active
- 2004-07-12 BR BRPI0412522-3A patent/BRPI0412522A/pt not_active IP Right Cessation
- 2004-07-12 DK DK04743347.9T patent/DK1646425T3/da active
- 2004-07-12 MX MXPA06000135A patent/MXPA06000135A/es active IP Right Grant
- 2004-07-12 GE GEAP20049216A patent/GEP20094648B/en unknown
- 2004-07-12 HR HRP20120721TT patent/HRP20120721T1/hr unknown
- 2004-07-12 WO PCT/GB2004/003006 patent/WO2005007241A1/en not_active Ceased
- 2004-07-12 AU AU2004257450A patent/AU2004257450B2/en not_active Expired
- 2004-07-12 CA CA2532199A patent/CA2532199C/en not_active Expired - Fee Related
-
2006
- 2006-01-05 CR CR8174A patent/CR8174A/es unknown
- 2006-01-09 TN TNP2006000006A patent/TNSN06006A1/en unknown
- 2006-01-10 IL IL173057A patent/IL173057A/en not_active IP Right Cessation
- 2006-01-12 US US11/330,671 patent/US8993546B2/en active Active
- 2006-01-13 ZA ZA200600374A patent/ZA200600374B/en unknown
- 2006-02-10 EC EC2006006360A patent/ECSP066360A/es unknown
- 2006-02-10 NO NO20060676A patent/NO336181B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Beshbishy et al. | Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo | |
| Bahia et al. | Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas disease | |
| NO20060676L (no) | Parasittisidiske sammensetninger | |
| KR20080090489A (ko) | 살균제 조성물 및 그 사용 방법 | |
| NO20010531L (no) | Medisinske aerosolformuleringer | |
| WO2002081453A8 (fr) | Hiohydantoïnes et leur utilisation dans le traitement du diabete | |
| MA28748B1 (fr) | Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques | |
| BR0307974A (pt) | Composição anti-parasita | |
| EP2648703A1 (en) | Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections | |
| TR200606411T1 (tr) | Vajinite karşı bir triazol içeren bileşimler. | |
| Xu et al. | The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses | |
| AU2023201883B2 (en) | Anti-virus agent and method for treatment of viral infection | |
| US9474723B2 (en) | Anti-microbial composition | |
| Palit et al. | Oral therapy with amlodipine and lacidipine, 1, 4-dihydropyridine derivatives showing activity against experimental visceral leishmaniasis | |
| Salomão et al. | In vitro and in vivo activities of 1, 3, 4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi | |
| DK1441769T3 (da) | Farmaceutiske formuleringer, der indeholder lave koncentrationer af peroxid, til behandling eller forebyggelse af vaginale infektioner | |
| Gu et al. | Novel virostatic agents against bluetongue virus | |
| Casarin et al. | Influence of glycemic control on Epstein-Bar and Cytomegalovirus infection in periodontal pocket of type 2 diabetic subjects | |
| EP3220923B1 (en) | Copolymer and method for treatment of bacterial infection | |
| Klein et al. | In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum | |
| Vanachayangkul et al. | Safety, pharmacokinetics, and liver-stage Plasmodium cynomolgi effect of high-dose ivermectin and chloroquine in Rhesus Macaques | |
| NO20081754L (no) | Anthelmintiske formuleringer | |
| Bifano et al. | Daclatasvir Pharmacokinetics in Healthy Subjects: No Clinically-Relevant Drug-Drug Interactions with Either Cyclosporine or Tacrolimus: 1081 | |
| Kory et al. | Retraction notice | |
| US10758620B2 (en) | Potentiated antimicrobial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |